firstli
inform
world
health
organ
decemb
current
outbreak
coronaviru
diseas
covid
involv
confirm
case
countri
februari
major
patient
pneumonia
show
symptom
includ
fever
cough
genom
sequenc
caus
novel
coronaviru
share
global
initi
share
influenza
data
gisaid
platform
januari
sequenc
novel
coronaviru
cov
show
close
similar
sever
acut
respiratori
syndromerel
coronavirus
sarsrcov
viru
use
entri
receptor
like
sarscov
coronaviru
studi
group
intern
committe
taxonomi
virus
design
viru
molecular
diagnosi
current
carri
onestep
quantit
rtpcr
qrtpcr
target
primer
probe
suggest
institut
china
germani
hong
kong
japan
thailand
usa
post
clinic
diagnosi
method
includ
ct
scan
also
util
identifi
case
hubei
provinc
china
februari
although
qrtpcr
assay
serv
goldstandard
method
detect
respiratori
infecti
virus
sarscov
merscov
current
qrtpcr
assay
target
caveat
first
due
high
similar
sarscov
primerprob
set
would
crossreact
second
sensit
assay
may
enough
confirm
suspici
patient
earli
time
point
admiss
inde
case
posit
ct
scan
result
neg
rtpcr
result
initi
present
report
perform
molecular
diagnosi
might
depend
primer
probe
reagent
compar
result
current
qrtpcr
analysi
molecular
diagnosi
present
studi
qrtpcr
analysi
perform
previous
report
primerprob
set
target
n
region
first
compar
analysi
variou
primerprob
set
laboratori
confirm
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
compar
analysi
laboratori
confirm
ten
primerprob
set
select
base
sequenc
inform
six
differ
nation
institut
center
diseas
control
figur
tabl
seven
ten
set
deriv
n
gene
three
set
deriv
gene
rdrp
orf
orf
dna
oligonucleotid
resuspend
nucleasefre
water
use
infect
experi
perform
biosafeti
laboratori
african
green
monkey
kidney
vero
cell
atcc
infect
clinic
isol
provid
korea
cdc
h
cultur
medium
contain
matur
infecti
virion
viru
medium
collect
viral
rna
isol
cultur
medium
use
qiaamp
viral
rna
extract
kit
qiagen
hilden
germani
accord
manufactur
instruct
code
sequenc
envelop
e
protein
clone
plasmid
pcr
amplifi
promot
primer
aatacgactcactatag
macrogen
inc
south
korea
termin
primer
gctagttattgctcagcgg
macrogen
pcr
premix
dye
kit
bioneer
inc
south
korea
pcr
product
use
vitro
transcript
templat
use
transcript
kit
invitrogen
inc
ca
usa
copi
number
vitro
transcrib
rna
calcul
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
rna
concentr
measur
fluoromet
promega
inc
wi
usa
standard
amount
vitro
produc
rna
use
e
primer
qrtpcr
produc
standard
curv
extract
nucleic
acid
sampl
test
compar
analysi
qrtpcr
n
region
use
target
sequenc
specif
gene
briefli
purifi
viral
rna
amplifi
reaction
solut
contain
step
rtpcr
mix
well
bio
inc
south
korea
nm
primer
probe
target
detect
qrtpcr
perform
cfx
touch
realtim
pcr
detect
system
biorad
hercul
ca
usa
qrtpcr
condit
appli
studi
program
follow
ung
incub
rt
incub
enzym
activ
serial
perform
minut
minut
minut
respect
thermal
cycl
perform
second
denatur
second
anneal
amplif
fortyf
cycl
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ct
valu
produc
neg
control
indic
reaction
done
asept
standard
curv
e
gene
primerprob
set
also
show
reaction
done
accordingli
r
valu
standard
curv
calcul
amplif
effici
indic
qrtpcr
reaction
done
optim
condit
viral
concentr
supernat
cell
lysat
determin
e
genebas
assay
tabl
ct
valu
rdrpsarsr
germani
hong
kong
china
low
concentr
copiesreact
respect
tabl
variou
primerprob
set
previous
report
detect
qrtpcr
assay
sensit
assay
may
enough
confirm
suspici
patient
earli
stage
infect
nevertheless
compar
result
current
qrtpcr
analysi
molecular
diagnosi
present
studi
first
compar
analysi
variou
primerprob
set
target
n
region
perform
qrtpcr
laboratori
confirm
case
target
region
china
set
might
sensit
set
usa
japan
set
may
recommend
sensit
qrtpcr
assay
n
region
therefor
appropri
combin
china
usa
japan
set
select
sensit
reliabl
laboratori
confirm
appreci
nation
cultur
collect
pathogen
korea
cdc
provid
clinic
sar
